文献速递其他结缔组织病

TAPSE/sPAP比值可辅助DETECT算法诊断SSc相关肺动脉高压

In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

DETECT算法PPV为31.3%,而TAPSE/sPAP比值( cut-off 0.60 mm/mmHg)的PPV为62.5%。结论提示在DETECT算法第2步总分>35的SSc患者中,TAPSE/sPAP比值可用于进一步筛选需右心导管确诊PAH的患者。

要点

  • DETECT算法筛查PAH的PPV为31.3%,TAPSE/sPAP比值(≤0.60 mm/mmHg)的PPV为62.5%。
  • TAPSE/sPAP比值在未转诊右心导管者中高于转诊者[0.83 vs 0.74 mm/mmHg, P<0.05]。
  • DETECT算法第2步总分>35的SSc患者,可用TAPSE/sPAP比值进一步筛选需右心导管者。

核心结论

  • 在DETECT算法第2步总分>35的SSc患者中,TAPSE/sPAP比值可进一步筛选需右心导管确诊PAH的患者。

主要发现

  • DETECT算法第1步推荐34例(66.7%)患者行超声心动图,第2步推荐16例(31.4%)患者行右心导管。
  • 右心导管确诊PAH 5例,DETECT算法PPV为31.3%。
  • TAPSE/sPAP比值在未转诊右心导管者中高于转诊者[0.83(0.35-1.40)mm/mmHg vs 0.74(0.12-1.09)mm/mmHg,P<0.05]。
  • 以0.60 mm/mmHg为 cut-off,8例(15.7%)SSc患者TAPSE/sPAP比值≤0.60 mm/mmHg,其中右心导管确诊PAH 5例,PPV为62.5%。
  • 多因素回归显示TAPSE/sPAP比值与年龄[β=-0.348(95%CI:-0.011,-0.003);P<0.01]、DETECT算法第1步[β=1.023(95%CI:0.006,0.024);P<0.01]及第2步[β=-1.758(95%CI:-0.059,-0.021);P<0.0001]相关。

关键数值与推荐

  • TAPSE/sPAP比值 cut-off 为0.60 mm/mmHg,其PPV为62.5%,DETECT算法PPV为31.3%。
  • DETECT算法第2步总分>35的SSc患者中,TAPSE/sPAP比值可用于进一步筛选需右心导管者。

临床怎么用

  • 对SSc患者行PAH筛查时,DETECT算法第2步总分>35者可用TAPSE/sPAP比值(≤0.60 mm/mmHg)辅助判断是否需右心导管确诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Early detection of pulmonary arterial hypertension (PAH) is crucial for improving patient outcomes. The aim of this study was to compare the positive predictive value (PPV) of the echocardiography-derived tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio with that of the DETECT algorithm for PAH screening in a cohort of SSc patients. METHODS: Fifty-one SSc patients were screened for PAH using the DETECT algorithm and echocardiography. RESULTS: Echocardiography was recommended by the DETECT algorithm step 1 in 34 patients (66.7%). Right heart catheterization (RHC) was recommended by the DETECT algorithm step 2 in 16 patients (31.4%). PAH was confirmed by RHC in 5 patients. The DETECT algorithm PPV was 31.3%. The TAPSE/sPAP ratio was higher in SSc patients not referred for RHC than in SSc patients referred for RHC according to the DETECT algorithm step 2 [0.83 (0.35-1.40) mm/mmHg vs 0.74 (0.12-1.09) mm/mmHg, P < 0.05]. Using a cut-off of 0.60 mm/mmHg, 8 (15.7%) SSc patients had a TAPSE/sPAP ratio of ≤0.60 mm/mmHg. PAH was confirmed by RHC in 5 patients. The PPV of TAPSE/sPAP was 62.5%. In multiple regression analysis, TAPSE/sPAP was associated with age [β coefficient = -0.348 (95% CI: -0.011, -0.003); P < 0.01], DETECT algorithm step 1 [β coefficient = 1.023 (95% CI: 0.006, 0.024); P < 0.01] and DETECT algorithm step 2 (β coefficient = -1.758 [95% CI: -0.059, -0.021]; P < 0.0001). CONCLUSION: In SSc patients with a DETECT algorithm step 2 total score of >35, the TAPSE/sPAP ratio can be used to further select patients requiring RHC to confirm PAH diagnosis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Colalillo A, Grimaldi MC, Vaiarello V, et al. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis. Rheumatology (Oxford). 2022. PMID: 34605890. doi:10.1093/rheumatology/keab748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。